Irene Guadalupe Aguilar Garcia

Dr. Irene Guadalupe Aguilar Garcia


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
DMDiana Emilia Martínez-Fernández
Diana Emilia Martínez-Fernández
David Fernández-QuezadaDavid Fernández-Quezada
David Fernández-Quezada
AGAndrea P. Garzón-Partida
Andrea P. Garzón-Partida
IGIrene Guadalupe Aguilar Garcia
Irene Guadalupe Aguilar Garcia
JGJoaquin Garcia-Estrada
Joaquin Garcia-Estrada
SLSonia Luquin
Sonia Luquin
Substance use disorder (SUD) significantly impacts public health, economics, and legal systems worldwide. Eye Movement Desensitization and Reprocessing (EMDR) was initially developed in the late 1980s as a therapeutic approach for post-traumatic stress disorder (PTSD), using bilateral stimulation to integrate traumatic memories with calming physiological responses. However, the effectiveness of EMDR in treating SUD remains unclear. This study aims to conduct a systematic review and meta-analysis of the impact of EMDR therapy on craving reduction in individuals with SUD. The search was conducted using databases such as PubMed and Web of Science, focusing on studies that measured craving and employed EMDR interventions. Both random and fixed effects models were used to pool effect sizes, utilizing an R software meta-package (R-4.4.1). The study adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The results indicated a significant reduction in cravings among patients undergoing EMDR therapy. Specifically, under the fixed effect model, the standardized mean difference (SMD) was −0.866 with a 95% confidence interval ranging from −1.121 to −0.611 (z = −6.66, p < 0.0001). These findings may demonstrate the significant efficacy of EMDR therapy in decreasing cravings in people with SUD.

Verified
Journal Article
Open access
PDF file
LPLiliana Rebolledo Pérez
Liliana Rebolledo Pérez
JHJorge Hernández-Bello
Jorge Hernández-Bello
AMAlicia Martínez-Ramos
Alicia Martínez-Ramos
RCRolando Castañeda
Rolando Castañeda
David Fernández-QuezadaDavid Fernández-Quezada
David Fernández-Quezada
IGIrene Guadalupe Aguilar Garcia
Irene Guadalupe Aguilar Garcia
Tau protein is essential for the structural stability of neurons, particularly through its role in microtubule assembly and axonal transport. However, when abnormally hyperphosphorylated or cleaved, Tau can aggregate into insoluble forms that disrupt neuronal function, contributing to the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease (AD). Emerging evidence suggests that similar Tau-related alterations may occur in individuals with chronic exposure to psychoactive substances. This review compiles experimental, clinical, and postmortem findings that collectively indicate a substance-specific influence on Tau dynamics. Alcohol and opioids, for instance, promote Tau hyperphosphorylation and fragmentation through the activation of kinases such as GSK-3β and CDK5, as well as proteases like caspase-3, leading to neuroinflammation and microglial activation. Stimulants and dissociatives disrupt insulin signaling, increase oxidative stress, and impair endosomal trafficking, all of which can exacerbate Tau pathology. In contrast, cannabinoids and psychedelics may exert protective effects by modulating kinase activity, reducing inflammation, or enhancing neuroplasticity. Psychedelic compounds such as psilocybin and harmine have been demonstrated to decrease Tau phosphorylation and facilitate cognitive restoration in animal models. Although the molecular mechanisms differ across substances, Tau consistently emerges as a convergent target altered in substance-related cognitive disorders. Understanding these pathways may provide not only mechanistic insights into drug-induced neurotoxicity but also identify Tau as a valuable biomarker and potential therapeutic target for the prevention or treatment of cognitive decline associated with substance use.

15 March 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
IGIrene Guadalupe Aguilar Garcia
Irene Guadalupe Aguilar Garcia
IJIsmael Jiménez-Estrada
Ismael Jiménez-Estrada
RCRolando Castañeda
Rolando Castañeda
JAJonatan Alpirez
Jonatan Alpirez
GMGerardo Mendizabal-Ruiz
Gerardo Mendizabal-Ruiz
IGIrene Guadalupe Aguilar Garcia
Irene Guadalupe Aguilar Garcia
Glioblastoma Multiforme (GBM) is a tumor that infiltrates several brain structures. GBM is associated with abnormal motor activities resulting in impaired mobility, producing a loss of functional motor independence. We used a GBM xenograft implanted in the striatum to analyze the changes in Y (vertical) and X (horizontal) axis displacement of the metatarsus, ankle, and knee. We analyzed the steps dissimilarity factor between control and GBM mice with and without anastrozole. The body weight of the untreated animals decreased compared to treated mice. Anastrozole reduced the malignant cells and decreased GPR30 and ERα receptor expression. In addition, we observed a partial recovery in metatarsus and knee joint displacement (dissimilarity factor). The vertical axis displacement of the GBM+anastrozole group showed a difference in the right metatarsus, right knee, and left ankle compared to the GBM group. In the horizontal axis displacement of the right metatarsus, ankle, and knee, the GBM+anastrozole group exhibited a difference at the last third of the step cycle compared to the GBM group. Thus, anastrozole partially modified joint displacement. The dissimilarity factor and the vertical and horizontal displacements study will be of interest in GBM patients with locomotion alterations. Hindlimb displacement and gait locomotion analysis could be a valuable methodological tool in experimental and clinical studies to help diagnose locomotive deficits related to GBM.

24 June 2026 in NeuroSci
Verified
Journal Article
Open access
PDF file
HMHANNA VALERIA VENEGAS MORA
HANNA VALERIA VENEGAS MORA
OIOctavio Ispanixtlahuatl-Meraz
Octavio Ispanixtlahuatl-Meraz
DMDiana Emilia Martínez-Fernández
Diana Emilia Martínez-Fernández
IGIrene Guadalupe Aguilar Garcia
Irene Guadalupe Aguilar Garcia
David Fernández-QuezadaDavid Fernández-Quezada
David Fernández-Quezada
Noise exposure has become an increasingly prevalent public health concern, with effects extending beyond the auditory system. Accumulating evidence indicates that chronic noise exposure induces both structural and functional alterations in the central nervous system, ultimately affecting cognitive and emotional processes. This review summarizes the impact of noise on key brain regions, including the hippocampus, prefrontal cortex, and auditory cortex. Structurally, noise exposure is associated with reduced neurogenesis, dendritic remodeling, synaptic loss, alterations in white matter and changes in glial activity. Functionally, it disrupts synaptic plasticity mechanisms—such as long-term potentiation and long-term depression—as well as neuronal connectivity, leading to impairments in higher-order cognitive and behavioral functions. These effects are mediated by interconnected mechanisms, including activation of the hypothalamic–pituitary–adrenal axis, neuroinflammation, oxidative stress, and alterations in neurotrophic signaling.

2 November 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
JAJonatan Alpirez
Jonatan Alpirez
LLLilia Carolina Leon-Moreno
Lilia Carolina Leon-Moreno
IGIrene Guadalupe Aguilar Garcia
Irene Guadalupe Aguilar Garcia
RCRolando Castañeda
Rolando Castañeda
JJJudith Marcela Dueñas Jimenez
Judith Marcela Dueñas Jimenez
IGIrene Guadalupe Aguilar Garcia
Irene Guadalupe Aguilar Garcia
Traumatic brain injury has been the leading cause of mortality and morbidity in human beings. One of the most susceptible structures to this damage is the hippocampus due to cellular and synaptic loss and impaired hippocampal connectivity to the brain, brain stem, and spinal cord. Thus, hippocampal damage in rodents using a stereotaxic device could be an adequate method to study a precise lesion from CA1 to the dentate gyrus structures. We studied male and female rats and mice, analyzing hindlimb locomotion kinematics changes to compare the locomotion kinematics using the same methodology in rodents. We measure (1) the vertical hindlimb metatarsus, ankle, and knee joint vertical displacements (VD) and (2) the factor of dissimilarity (DF). The VD in intact rats in metatarsus, ankle, and knee joints differs from that in intact mice in similar joints. In rats, the vertical displacement through the step cycle changed in the left and right metatarsus, ankle, and knee joints compared to the intact group versus the lesioned group. More subtle changes were also observed in mice. DF demonstrates contrasting results when studying locomotion kinematics of mice or rats and sex-dependent differences. Thus, a precise lesion in a rodent’s hippocampal structure discloses some hindlimb locomotion changes related to species and sex. Thus, we only have a qualitative comparison between murine species. In order to make a comparison with other species, we should standardize the model.

5 November 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
IGIrene Guadalupe Aguilar Garcia
Irene Guadalupe Aguilar Garcia
JAJonatan Alpirez
Jonatan Alpirez
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle
WTWalter Ángel Trujillo-Rangel
Walter Ángel Trujillo-Rangel
David Fernández-QuezadaDavid Fernández-Quezada
David Fernández-Quezada
RCRolando Castañeda
Rolando Castañeda
Stroke is the third cause of death worldwide and a health problem, and current therapy continues to be very poor. It promotes an alteration associated with excitotoxicity, oxidative stress, and inflammatory processes, exacerbating the damage in the brain. Although cortical areas are the most affected by stroke, the hippocampus can be impacted in the long term through the pathways it connects with these areas, which are associated further with motor alterations; this encourages the search for new therapeutic approaches. Omega-5, being an antioxidant, participates in regulating oxidative stress. A recently designed nanoemulsified compound coupled with pomegranate seed oil (NanoPSO) maintains bioavailability in the body for longer. Omega-5 NanoPSO is more effective in different models of neurodegenerative diseases and metabolic disorders. Therefore, it is important to analyze the effect of omega-5 NanoPSO on ischemic damage through changes in the hippocampus, oxidative mechanisms, and behavioral outcomes. Male Wistar rats were used in five groups; three groups were subjected to an ischemic event through bilateral occlusion of the carotid arteries. An ischemia group received omega-5 NanoPSO after injury, and another group received omega-5 NanoPSO performed two weeks before the ischemic event and three weeks after the surgical process. The control and sham groups did not show changes in the hippocampus and behavior. In the ischemia group, neuronal loss, oxidative stress, and a higher expression of astrocytes were maintained in the hippocampal region, and behavior was modified. In the post and pre-treatment group with omega-5 NanoPSO, we observed reduced damage, glial proliferation, and oxidative stress. It increased neuron survival in the hippocampal region and improved the locomotion. These results highlight its promise for use in clinical settings to treat patients suffering from ischemic brain injury.